PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Department of Medicine, Division of Nephrology and Hypertension, Vanderbilt University Medical Center, Nashville, Tennessee, USA. Electronic address: alp.ikizler@vumc.org.\', \'Centre for Clinical and Experimental Transplantation, The University of Adelaide, Adelaide, Australia.\', \'Internal Medicine-Nephrology, The Ohio State University Wexner Medical Center, Columbus, Ohio, USA.\', \'Unité Mixte de Recherche S 1155, Sorbonne Université, Université Pierre et Marie Curie Paris 06 and Institut National de la Santé et de la Recherche Médicale, Paris, France; Division of Nephrology, Centre Hospitalier du Mans, Le Mans, France.\']
?:citedBy
  • -1
?:creator
?:doi
?:doi
  • S0085-2538(21)00391-410.1016/j.kint.2021.04.007
?:hasPublicationType
?:journal
  • Kidney international
is ?:pmid of
?:pmid
?:pmid
  • 33931226
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • 3.238
?:rankingScore_hIndex
  • 246
is ?:relation_isRelatedTo_publication of
?:title
  • Immune response to SARS-CoV-2 infection and vaccination in patients receiving kidney replacement therapy.
?:type
?:year
  • 2021

Metadata

Anon_0  
expand all